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Abstract
Background: Klf5 plays an important role in maturation and maintenance of the mouse ocular surface. Here, we quantify
WT and Klf5-conditional null (Klf5CN) corneal gene expression, identify Klf5-target genes and compare them with the
previously identified Klf4-target genes to understand the molecular basis for non-redundant functions of Klf4 and Klf5 in the
cornea.
Methodology/Principal Findings: Postnatal day-11 (PN11) and PN56 WT and Klf5CN corneal transcriptomes were quantified
by microarrays to compare gene expression in maturing WT corneas, identify Klf5-target genes, and compare corneal Klf4-
and Klf5-target genes. Whole-mount corneal immunofluorescent staining was employed to examine CD45+ cell influx and
neovascularization. Effect of Klf5 on expression of desmosomal components was studied by immunofluorescent staining
and transient co-transfection assays. Expression of 714 and 753 genes was increased, and 299 and 210 genes decreased in
PN11 and PN56 Klf5CN corneas, respectively, with 366 concordant increases and 72 concordant decreases. PN56 Klf5CN
corneas shared 241 increases and 98 decreases with those previously described in Klf4CN corneas. Xenobiotic metabolism
related pathways were enriched among genes decreased in Klf5CN corneas. Expression of angiogenesis and immune
response-related genes was elevated, consistent with neovascularization and CD45+ cell influx in Klf5CN corneas. Expression
of 1574 genes was increased and 1915 genes decreased in WT PN56 compared with PN11 corneas. Expression of ECM-
associated genes decreased, while that of solute carrier family members increased in WT PN56 compared with PN11
corneas. Dsg1a, Dsg1b and Dsp were down-regulated in Klf5CN corneas and their corresponding promoter activities were
stimulated by Klf5 in transient co-transfection assays.
Conclusions/Significance: Differences between PN11 and PN56 corneal Klf5-target genes reveal dynamic changes in
functions of Klf5 during corneal maturation. Klf5 contributes to corneal epithelial homeostasis by regulating the expression
of desmosomal components. Klf4- and Klf5-target genes are largely distinct, consistent with their non-redundant roles in the
mouse cornea.
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Introduction
The transparent and refractive cornea plays a central role in
vision. Abnormal development and/or maintenance of the cornea
result in severe defects in vision [1,2]. Molecular and cellular
events involved in corneal development, maturation and mainte-
nance have been studied in great detail [3–9]. Members of
different transcription factor families including Kru¨ppel-like
factors (KLF) influence corneal morphogenesis [10–25]. More
than 17 members of the KLF family have been identified in
mammals [26,27], many of which are expressed in the ocular
surface in varying amounts [17,28,29]. Among them, structurally
related Klf4 and Klf5 are two of the most highly expressed
transcription factors in the mouse cornea [29,30]. Our previous
studies demonstrated that both Klf4 and Klf5 are essential for
normal maturation and maintenance of the mouse ocular surface
[22,31].
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Klf4 and Klf5 exert tissue-dependent and non-redundant
influences on the mouse ocular surface in spite of possessing an
identical DNA-binding domain. Conditional disruption of Klf4 in
the developing mouse ocular surface resulted in numerous defects
including corneal epithelial fragility, stromal edema, altered
stromal collagen fibril organization, endothelial vacuolation and
loss of mucin producing conjunctival goblet cells [21,22,32].
Similar conditional disruption of Klf5 also resulted in multiple
defects including translucent cornea, abnormal eyelids with
malformed meibomian glands and a conjunctiva devoid of goblet
cells [31]. Microarray comparison of WT and Klf4CN corneal and
conjunctival transcriptomes identified significant differences in
Klf4-target genes in these adjacent tissues, suggesting tissue-
dependent functions for Klf4 [21,33].
Here, we test the hypothesis that the basis for non-redundant
functions of structurally related Klf4 and Klf5 lies in their distinct
target genes in the mouse cornea. As most of the Klf5CN ocular
surface defects appeared in post-eyelid opening stages [31], we
identified the corneal Klf5-target genes before eyelid opening at
PN11 and in young adults at PN56. This study design also enabled
us to examine the changes in gene expression accompanying WT
corneal maturation between PN11 and PN56. We report that Klf5
regulates a wide array of genes associated with a diverse spectrum
of functions such as cell adhesion, barrier function, maintenance of
hydration, and xenobiotic metabolism. We also show that the
corneal Klf5- and Klf4-target genes are largely distinct, consistent
with their non-redundant roles in the mouse cornea. Furthermore,
we identified significant differences in Klf5-target genes between
PN11 and PN56, revealing dynamic changes in Klf5 functions in
the maturing cornea.
Results
Microarray analysis and validation of results
We compared the WT and Klf5CN corneal transcriptomes in
immature PN11 corneas just before eyelid opening and in young
adult PN56 corneas to identify the changes in gene expression
associated with post-eyelid opening Klf5CN corneal phenotype
[31]. We also compared the PN56 Klf5-target genes with those
reported previously for Klf4 [21] to determine the extent of
overlap between Klf4- and Klf5-target genes. Scatter plots of the
WT vs. Klf5CN comparisons at PN11 (Fig. 1A) and PN56 (Fig. 1B),
and the PN11 WT vs. PN56 WT comparison (Fig. 1C) show
overall distribution of the panels measured by these microarrays. A
large number of genes with distinct or overlapping expression were
identified between (i) corneal Klf5-target genes at PN11 and PN56
(Fig. 1D), (ii) corneal Klf4- [21] and Klf5-target genes at PN56
(Fig. 1E), and (iii) the genes modulated during WT corneal
maturation compared with the Klf5-target genes at PN11 and
PN56 (Fig. 1F). Microarray results were validated by QPCR
comparison of selected genes whose expression was increased,
decreased or relatively unaffected in PN11 or PN56 Klf5CN
Figure 1. Comprehensive view of the changes in PN11 and PN56 Klf5CN corneal gene expression. A–C. Scatter plots showing the
significantly affected genes in (A) PN11 Klf5CN compared with the WT corneas, (B) PN56 Klf5CN compared with the WT corneas, and (C) PN56 WT
compared with PN11 WT corneas. (D). Venn representation of numbers of unique characterized genes which are differentially expressed in Klf5CN
corneas vs. WT corneas at PN11 or PN56. In parentheses is the percentage of genes showing valid .2-fold changes between PN11 WT and PN56 WT
samples. (E). Venn representation of the overlap between Klf4- and Klf5-target genes in PN56 corneas. (F). Venn representation of the overlap
between aggregate Klf5-target genes at PN11 and PN56, and genes modulated during WT corneal maturation.
doi:10.1371/journal.pone.0044771.g001
Corneal Klf5-Target Genes
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corneas (Fig. 2). There was a general conformity between the
microarray and QPCR results, indicating that the microarray
results accurately represent the changes in Klf5CN corneal gene
expression at these two stages (Fig. 2).
Changes in Klf5-target genes during corneal maturation
Table 1 gives a complete breakdown of the changes in 21,815
unique characterized genes represented on the microarray. Corneal
ablation of Klf5 resulted in decreased expression of 299 and 210 genes
at PN11 and PN56 respectively (with 72 concordant decreases), and
increased expression of 714 and 753 genes (with 366 concordant
increases; Fig. 1D; Table 1). About 41% of the genes modulated in
Klf5CN corneas were also modulated during WT corneal maturation
between PN11 and PN56, compared with only 15% for those
unaffected by disruption of Klf5 (Table 1), providing evidence for the
important role of Klf5 in regulating post-eyelid opening corneal
maturation. The top 50 most affected genes in PN11 and PN56
Klf5CN corneas are listed in Tables 2, 3, 4, and 5 (See Tables S2, S3,
S4, S5 for the complete list).
Changes in gene expression during WT corneal
maturation
Comparison of the WT corneal transcriptomes at PN11 and
PN56 revealed that the expression of 1574 genes decreased and
1915 genes increased by more than 2-fold between PN11 and
PN56 (Fig. 1C). The 50 most affected genes in the WT PN56
compared with PN11 corneas are listed in Tables 6–7 (See Tables
S6 and S7 for the complete list). Transcripts encoding different
collagens and other major extracellular matrix (ECM)-related
proteins were significantly decreased between PN11 and PN56,
suggesting that most of the ingredients for stromal ECM are
produced before or around eyelid opening (Tables 7 and 8).
Similarly, expression of Adam family proteinases and other MMPs
that play significant roles in remodeling ECM [34] also was
sharply decreased between PN11 and PN56 (Table 9), providing
Figure 2. Validation of microarray results by QPCR analysis of the expression of selected genes. Note that the relative levels are plotted
on a log scale.
doi:10.1371/journal.pone.0044771.g002
Corneal Klf5-Target Genes
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further evidence that most of the stromal ECM is in place by
eyelid opening stage and little stromal remodeling occurs in the
adult cornea [35].
Expression of several cell-junctional complexes and late markers
of stratified squamous epithelial cells increased significantly
between PN11 and PN56 (shown in bold in Table 6), when much
of the corneal epithelial stratification occurs. In addition,
expression of several members of the solute carrier family was
significantly elevated between PN11 and PN56 (Table 10),
reflecting the elevated need for solute transport in metabolically
active adult corneas. While specific corneal functions of many of
these solute carrier family members are not known, it is
noteworthy that mutations in SLC4A11 and SLC16A12 are
associated with congenital hereditary endothelial dystrophy
(CHED) [36] and microcornea [37], respectively. Another
important change that takes place between PN11 and PN56
corneas is the increased expression of several oxidative stress
related genes including ceruloplasmin, an antioxidant enzyme
upregulated in different neurodegenerative disorders including
glaucoma [38,39], Arachidonate lipoxygenase-12 and -15, which
promote epithelial wound healing and host defense [40], carbonic
anhydrase-2, -12, and -13, overexpressed in human glaucoma
[41–43], and calcium binding proteins S100A8 and A9 (Table 6),
suggesting an increase in oxidative stress in the adult compared
with the PN11 corneas.
Differences in PN56 corneal Klf4- and Klf5-target genes
Comparison of the PN56 corneal Klf5-target genes with those
described previously for Klf4 [21] identified 260 common targets
(204 increased and 56 decreased; Fig. 1E; Tables S8 and S9), with
many more modulated exclusively in the Klf4CN (270 increased
and 349 decreased) or Klf5CN (512 increased and 109 decreased)
corneas. Most of the common increases in Klf4CN and Klf5CN
corneas are associated with immune response, reflecting enhanced
inflammatory conditions in those corneas. Regulation of largely
distinct sets of target genes by Klf4 and Klf5 is consistent with their
non-redundant functions in the mouse cornea [22,31].
Elevated immune response in Klf5CN corneas
Canonical pathway analysis of the aggregate Klf5-target genes
identified 26 significantly (p,0.001) enriched pathways, predom-
inantly associated with immune function (Table S10). Expression
of most of the genes associated with these pathways was increased,
increasing the likelihood that these pathways represent indirect
response to disruption of Klf5. To overcome this limitation, we
repeated pathway analyses selectively for the genes with decreased
expression in Klf5CN corneas. Several xenobiotic stress response-
related pathways were predominantly enriched in genes with
decreased expression upon disruption of Klf5, suggesting that Klf5
plays a role in xenobiotic stress response in the cornea (Table 11).
Expression of 107 of 368 genes (29.1%) containing ‘‘immun’’ or
‘‘inflamm’’ in the GO Biological Process notation was increased,
while expression of only seven of these genes decreased in PN11 or
PN56 Klf5CN corneas (Table S11). Increased expression of the
immune response related genes, together with the previously
reported hypercellularity of the Klf5CN corneal stroma [31]
suggested a robust increase in immune-response in the Klf5CN
corneas. Immunofluorescent staining of corneal flat mounts with
anti-CD45 antibody demonstrated increased influx of CD45+ cells
distributed throughout the Klf5CN compared with the WT corneal
stroma sparsely populated with CD45+ cells (Fig. 3).
Klf5CN corneal neovascularization (CNV)
Whole-mount corneal immunofluorescent staining with anti-
CD31 and anti-Lyve1 antibody revealed that the enhanced
inflammatory environment in Klf5CN corneas is accompanied
by extensive CNV (Fig. 4). Klf5CN CNV was apparent as early as
PN21, when the Lyve1+ lymph vessels were much more
pronounced and penetrated deeper into the central cornea, unlike
the CD31+ blood vessels that remained in the peripheral region
without reaching the central cornea (Fig. 4). By PN56, CNV was
observed throughout the Klf5CN cornea, with blood vessels
overtaking lymph vessels, which appeared to have regressed
(Fig. 4). Examination of the XY-stack of confocal images revealed
that CD31+ blood vessels are present in the anterior of the Klf5CN
corneal stroma, unlike the Lyve1+ lymph vessels located in the
posterior (Fig. 4).
Table 1. Distribution of modulated genes.
Developmental changes
PN56 vs. PN11 PN11: Effects in Klf5CN vs. WT corneas
Increased Decreased Unchanged
PN56: Effects in Klf5CN vs. WT corneas Increased Increased 37 (22) 0 (0) 16 (6)
Decreased 99 (42) 1 (0) 175 (48)
Unchanged 230 (79) 1 (0) 194 (44)
Decreased Increased 0 (0) 25 (17) 47 (22)
Decreased 0 (0) 3 (1) 17 (5)
Unchanged 1 (0) 44 (29) 73 (26)
Unchanged Increased 58 (18) 31 (11) 1360 (128)
Decreased 62 (7) 55 (7) 1503 (80)
Unchanged 227 (16) 139 (48) 17,417 (304)
Numbers of unique characterized genes which are differentially expressed in Klf5CN vs. WT corneas at PN11 or at PN56 (rows) are shown. Rows are broken down
according to developmental changes, i.e., differences between PN56 WT and PN11 WT corneas, as designated in the shaded column. Data sets discordant between
PN11 and PN56 (i.e., increased in PN11 Klf5CN but decreased in PN56 Klf5CN, or vice versa) are too small to be meaningful. Number of genes which also show valid .2-
fold changes in PN56 Klf4CN cornea are shown in parentheses.
doi:10.1371/journal.pone.0044771.t001
Corneal Klf5-Target Genes
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Table 2. Top 50 genes whose expression is most decreased in PN11 Klf5CN compared with the WT corneas.
Gene symbol Description
Mean log
intensity in WT
Mean log
intensity in
Klf5CN Fold Difference
Klf5 Kru¨ppel-like factor 5 9.10 3.87 0.03
Aqp3 aquaporin 3 11.11 7.54 0.08
Folr1 folate receptor 1 (adult) 8.52 5.01 0.09
Krt4 keratin 4 7.33 4.12 0.11
Serpinb3a serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A 7.10 3.90 0.11
Ces3 carboxylesterase 3 8.71 5.60 0.12
Gkn1 gastrokine 1 6.21 3.35 0.14
Snx31 sorting nexin 31 8.59 5.84 0.15
Adh6b alcohol dehydrogenase 6B (class V) 9.35 6.60 0.15
Ppp1r3c protein phosphatase 1, regulatory (inhibitor) subunit 3C 7.14 4.50 0.16
Txnip thioredoxin interacting protein 9.25 6.63 0.16
Scd2 stearoyl-Coenzyme A desaturase 2 8.88 6.27 0.16
Cyp2b19 cytochrome P450, family 2, subfamily b, polypeptide 19 6.29 3.68 0.16
Cnpy1 canopy 1 homolog (zebrafish) 5.95 3.40 0.17
Pax6 paired box gene 6 9.08 6.60 0.18
Acaa2 acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) 9.39 6.94 0.18
Syt7 synaptotagmin VII 7.12 4.73 0.19
Sfrp1 secreted frizzled-related protein 1 9.60 7.21 0.19
Paqr5 progestin and adipoQ receptor family member V 8.32 5.98 0.20
Rapgef3 Rap guanine nucleotide exchange factor (GEF) 3 5.97 3.65 0.20
Fgf21 fibroblast growth factor 21 6.96 4.66 0.20
Acsm1 acyl-CoA synthetase medium-chain family member 1 8.38 6.10 0.21
Jakmip1 janus kinase and microtubule interacting protein 1 7.64 5.40 0.21
Es22 esterase 22 5.56 3.33 0.21
Gldc glycine decarboxylase 7.03 4.83 0.22
Ripply3 ripply3 homolog (zebrafish) 6.99 4.83 0.22
Bre brain and reproductive organ-expressed protein 9.45 7.28 0.22
Sox15 SRY-box containing gene 15 8.13 5.97 0.22
Gpt glutamic pyruvic transaminase, soluble 8.29 6.18 0.23
Tkt transketolase 9.66 7.55 0.23
Stk35 serine/threonine kinase 35 6.18 4.07 0.23
Ngef neuronal guanine nucleotide exchange factor 6.49 4.39 0.23
Akr1b7 aldo-keto reductase family 1, member B7 9.73 7.63 0.23
Slc16a12 solute carrier family 16 (monocarboxylic acid transporters), member 12 8.60 6.55 0.24
Pmm1 phosphomannomutase 1 8.68 6.64 0.24
Sdc1 syndecan 1 8.01 5.99 0.25
Mamdc2 MAM domain containing 2 8.05 6.03 0.25
Ckmt1 creatine kinase, mitochondrial 1, ubiquitous 9.50 7.49 0.25
Tm9sf2 transmembrane 9 superfamily member 2 8.91 6.92 0.25
Bnc1 basonuclin 1 10.00 8.03 0.26
Cps1 carbamoyl-phosphate synthetase 1 6.29 4.34 0.26
Shmt1 serine hydroxymethyltransferase 1 (soluble) 5.82 3.88 0.26
Angptl7 angiopoietin-like 7 11.61 9.68 0.26
Ascl2 achaete-scute complex homolog 2 (Drosophila) 5.35 3.44 0.27
Padi4 peptidyl arginine deiminase, type IV 6.06 4.16 0.27
Fjx1 four jointed box 1 (Drosophila) 8.25 6.35 0.27
Slc22a18 solute carrier family 22 (organic cation transporter), member 18 6.68 4.79 0.27
Lemd1 LEM domain containing 1 5.71 3.83 0.27
Corneal Klf5-Target Genes
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Table 2. Cont.
Gene symbol Description
Mean log
intensity in WT
Mean log
intensity in
Klf5CN Fold Difference
Prss32 protease, serine, 32 6.95 5.11 0.28
Etv4 ets variant gene 4 (E1A enhancer binding protein, E1AF) 5.51 3.68 0.28
Genes whose expression is also decreased in the PN56 Klf5CN corneas are shown in bold.
doi:10.1371/journal.pone.0044771.t002
Table 3. Top 50 genes whose expression is most increased in PN11 Klf5CN compared with the WT corneas.
Gene symbol Description
Mean log intensity
in WT
Mean log intensity
in Klf5CN Fold Difference
Sftpd surfactant associated protein D 4.11 11.36 151.84
Ccl8 chemokine (C-C motif) ligand 8 5.31 12.04 105.55
Expi extracellular proteinase inhibitor 6.16 12.55 83.66
Lcn2 lipocalin 2 6.72 12.06 40.53
Retnla resistin like alpha 5.62 10.95 40.27
Ppbp pro-platelet basic protein 3.44 8.69 37.93
Ltf lactotransferrin 6.85 12.06 36.88
Cd209e CD209e antigen 3.32 8.17 28.77
Cxcl3 chemokine (C-X-C motif) ligand 3 3.32 8.13 27.94
Hp haptoglobin 3.63 8.36 26.49
S100a9 S100 calcium binding protein A9 (calgranulin B) 5.64 10.36 26.43
Ear11 eosinophil-associated, ribonuclease A family, member 11 3.32 8.01 25.81
Spink12 serine peptidase inhibitor, Kazal type 11 3.45 7.99 23.23
Cxcl17 chemokine (C-X-C motif) ligand 17 5.25 9.51 19.20
Cxcl2 chemokine (C-X-C motif) ligand 2 3.35 7.37 16.20
Cytip cytohesin 1 interacting protein 5.55 9.54 15.84
Flt1 FMS-like tyrosine kinase 1 4.11 8.09 15.80
Cxcl5 chemokine (C-X-C motif) ligand 5 6.62 10.56 15.41
Krt16 keratin 16 6.74 10.68 15.31
Sprr1a small proline-rich protein 1A 5.86 9.68 14.12
Nrsn1 neurensin 1 3.56 7.24 12.83
Ms4a6d membrane-spanning 4-domains, subfamily A, member 6D 5.46 9.07 12.27
Socs3 suppressor of cytokine signaling 3 6.08 9.66 11.96
Slfn4 schlafen 4 3.87 7.43 11.75
Slco1a5 solute carrier organic anion transporter family, member 1a5 3.54 7.07 11.58
S100a8 S100 calcium binding protein A8 (calgranulin A) 7.25 10.73 11.13
Ccl9 chemokine (C-C motif) ligand 9 6.52 9.99 11.11
Spink5 serine peptidase inhibitor, Kazal type 5 5.38 8.81 10.83
Cd14 CD14 antigen 6.11 9.53 10.71
Cp ceruloplasmin 7.60 10.98 10.40
Clec4d C-type lectin domain family 4, member d 3.72 7.08 10.26
Stfa2l1 stefin A2 like 1 5.88 9.22 10.13
Ccl6 chemokine (C-C motif) ligand 6 5.42 8.76 10.06
Ifi203 interferon activated gene 203 5.11 8.30 9.11
Chi3l1 chitinase 3-like 1 7.81 10.98 9.00
Ccl5 chemokine (C-C motif) ligand 5 3.32 6.47 8.89
Gcnt2 glucosaminyl (N-acetyl) transferase 2, I-branching enzyme 5.21 8.32 8.65
Sprr2a small proline-rich protein 2A 3.32 6.43 8.62
Corneal Klf5-Target Genes
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Table 3. Cont.
Gene symbol Description
Mean log intensity
in WT
Mean log intensity
in Klf5CN Fold Difference
Alox15 arachidonate 15-lipoxygenase 6.68 9.74 8.34
Acpp acid phosphatase, prostate 4.14 7.19 8.30
Ccl7 chemokine (C-C motif) ligand 7 3.65 6.70 8.30
Tm4sf1 transmembrane 4 superfamily member 1 7.39 10.43 8.22
Cxcl1 chemokine (C-X-C motif) ligand 1 5.99 9.01 8.08
Htra4 HtrA serine peptidase 4 3.32 6.33 8.02
Il1b interleukin 1 beta 4.95 7.95 8.01
Nckap1l NCK associated protein 1 like 3.44 6.42 7.90
Krt23 keratin 23 5.27 8.24 7.84
Plb1 phospholipase B1 4.05 7.01 7.77
Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 4.71 7.67 7.74
Slc26a4 solute carrier family 26, member 4 3.39 6.33 7.71
Genes whose expression is also increased in the PN56 Klf5CN corneas are shown in bold.
doi:10.1371/journal.pone.0044771.t003
Table 4. Top 50 genes whose expression is most decreased in PN56 Klf5CN compared with the WT corneas.
Gene symbol Description
Mean log
intensity in WT
Mean log
intensity in Klf5CN
Fold
Difference
Klf5 Kruppel-like factor 5 10.22 4.75 0.02
Gldc glycine decarboxylase 7.88 4.73 0.11
Ppp1r3c protein phosphatase 1, regulatory (inhibitor) subunit 3C 10.56 7.63 0.13
Gkn1 gastrokine 1 7.50 4.59 0.13
Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1 7.75 5.06 0.15
Enpep glutamyl aminopeptidase 9.38 6.72 0.16
Klk11 kallikrein related-peptidase 11 6.71 4.11 0.16
Folr1 folate receptor 1 (adult) 7.79 5.43 0.20
Cd55 CD55 antigen 6.58 4.25 0.20
Dsg1a desmoglein 1 alpha 11.33 9.06 0.21
Trpm3 transient receptor potential cation channel, subfamily M, member 3 7.20 4.98 0.21
Il1f5 interleukin 1 family, member 5 (delta) 7.78 5.58 0.22
Pygl liver glycogen phosphorylase 9.93 7.74 0.22
Ldlr low density lipoprotein receptor 6.63 4.51 0.23
Lect1 leukocyte cell derived chemotaxin 1 7.83 5.72 0.23
Car3 carbonic anhydrase 3 6.11 4.01 0.23
Ces3 carboxylesterase 3 10.11 8.04 0.24
Fam184b family with sequence similarity 184, member B 7.56 5.48 0.24
Mab21l1 mab-21-like 1 (C. elegans) 8.51 6.45 0.24
Paqr5 progestin and adipoQ receptor family member V 8.08 6.03 0.24
Dlg2 discs, large homolog 2 (Drosophila) 7.79 5.75 0.24
Sorbs2 sorbin and SH3 domain containing 2 9.45 7.41 0.24
Myo6 myosin VI 7.24 5.21 0.24
Tkt transketolase 9.65 7.62 0.25
Slc14a1 solute carrier family 14 (urea transporter), member 1 9.34 7.32 0.25
Col4a3 collagen, type IV, alpha 3 8.91 6.89 0.25
Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1 10.12 8.11 0.25
Vgll3 vestigial like 3 (Drosophila) 7.81 5.89 0.27
Corneal Klf5-Target Genes
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Klf5 regulates the expression of desmosomal
components Dsg1a, Dsg1b and Dsp
Desmosomes are essential for corneal epithelial homeostasis
[44–46]. Previously, we reported that Klf4 contributes to the
formation and maintenance of corneal epithelial permeability
barrier by regulating the expression of desmosomal components
[47]. Microarray data presented here revealed that desmosomal
components Dsg1a and Dsg1b are decreased in Klf5CN corneas
(Table 4, Tables S2 and S4). Consistent with the microarray data,
immunofluorescence revealed a sharp decrease in the epithelial
expression of desmogleins, and a moderate decrease in desmopla-
kin in the Klf5CN corneas (Fig. 5A). Next, we tested the effect of
Klf4 and/or Klf5 on Dsg1a, Dsg1b and Dsp promoter activities by
transient co-transfection assays in NCTC cells using the previously
described reporter vectors [47]. Dsg1a, Dsg1b, and Dsp promoter
activities were stimulated by 7.5-, 6.5- and 8.7-fold, 5.8-, 9.9- and
10.8-fold, and 9.6-, 3.5- and 9.6-fold, respectively, when co-
transfected with Klf4, Klf5, or both (Fig. 5B). Relative to Klf4,
Klf5 had a comparable effect on Dsg1a, stronger stimulatory effect
on Dsg1b and weaker stimulatory effect on Dsp promoter activities
(Fig. 5B). Co-transfection with both Klf4 and Klf5 did not result in
an additive or synergistic stimulation of these promoter activities
(Fig. 5B), suggesting that Klf4 and Klf5 function through the same
cis- elements within the Dsg1a, Dsg1b, and Dsp promoters [47].
Taken together with our previous report [47], these results
demonstrate that one of the ways by which Klf4 and Klf5
contribute to corneal epithelial homeostasis is by regulating the
expression of desmosomal components Dsg1a, Dsg1b and Dsp.
Influence of Klf4 and Klf5 on gene regulatory networks in
the cornea
In order to determine the influence of Klf4 and Klf5 on gene
regulatory networks in the cornea, we examined the expression of
other transcription factors in PN11 and PN56 WT and Klf5CN
corneas and compared them with the previous results from PN56
Klf4CN corneas [21]. Comparative analysis of the transcription
factors decreased in more than one dataset (i.e., (a) PN56 Klf4CN
vs. WT, (b) PN56 Klf5CN vs. WT, (c) PN11 Klf5CN vs. WT, and
(d) PN56 WT vs. PN11 WT) identified Pax6, Bnc1, Cux1, Tox and
Satb1 as common targets of Klf4 and Klf5 that were also
modulated during corneal maturation (Table 12). Pathway
analysis of the affected transcription factors revealed distinct
networks predominantly associated with development and tissue
homeostasis (Figures S2 and S3). The differences in these
associated networks in spite of the five common transcription
factor targets for Klf4 and Klf5 are consistent with their non-
redundant functions in the mouse cornea. Among the common
transcription factor targets of Klf4 and Klf5, while Pax6 and Bnc1
are known to regulate corneal epithelial homeostasis [5,14,48–52],
corneal functions of Cux1, Tox and Satb1 are not yet known.
Increased expression of Cux1, which suppresses collagen synthesis
[53], is consistent with the decreased expression of collagens
during WT corneal maturation. The transcription factors whose
Table 4. Cont.
Gene symbol Description
Mean log
intensity in WT
Mean log
intensity in Klf5CN
Fold
Difference
Abcc9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9 6.78 4.86 0.27
Mmab methylmalonic aciduria (cobalamin deficiency) type B homolog (human) 5.80 3.90 0.27
Tox thymocyte selection-associated high mobility group box 6.12 4.24 0.27
Crygb crystallin, gamma B 8.29 6.43 0.27
Ano4 anoctamin 4 5.57 3.71 0.28
Capsl calcyphosine-like 6.06 4.21 0.28
Dkk1 dickkopf homolog 1 (Xenopus laevis) 7.11 5.26 0.28
Usp19 ubiquitin specific peptidase 19 6.12 4.27 0.28
Ano9 anoctamin 9 6.62 4.77 0.28
Mt3 metallothionein 3 5.17 3.32 0.28
Glb1l2 galactosidase, beta 1-like 2 5.75 3.91 0.28
Kif26a kinesin family member 26A 6.71 4.87 0.28
Prss32 protease, serine, 32 8.46 6.67 0.29
Cyp2b19 cytochrome P450, family 2, subfamily b, polypeptide 19 5.36 3.59 0.29
Slc4a11 solute carrier family 4, sodium bicarbonate transporter-like, member 11 9.40 7.64 0.29
Cryaa crystallin, alpha A 8.39 6.65 0.30
Scrn1 secernin 1 5.67 3.93 0.30
Phlda2 pleckstrin homology-like domain, family A, member 2 6.20 4.47 0.30
Osbpl6 oxysterol binding protein-like 6 6.50 4.77 0.30
Prkcb protein kinase C, beta 8.48 6.77 0.31
Fxyd4 FXYD domain-containing ion transport regulator 4 7.29 5.59 0.31
Ipw imprinted gene in the Prader-Willi syndrome region 6.07 4.38 0.31
Genes whose expression is also decreased in the PN11 Klf5CN corneas are shown in bold.
doi:10.1371/journal.pone.0044771.t004
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Table 5. Top 50 genes whose expression is most increased in PN56 Klf5CN compared with the WT corneas.
Gene symbol Description
Mean log intensity
in WT
Mean log intensity
in Klf5CN Fold Difference
Ppbp pro-platelet basic protein 5.28 10.79 45.32
Sprr2d small proline-rich protein 2D 4.73 10.14 42.29
Cxcl3 chemokine (C-X-C motif) ligand 3 4.82 10.13 39.83
Clca2 chloride channel calcium activated 2 3.32 8.40 33.76
Fabp4 fatty acid binding protein 4, adipocyte 4.37 9.44 33.53
Cd163 CD163 antigen 3.74 8.57 28.62
Sprr2f small proline-rich protein 2F 6.65 11.49 28.60
Chi3l3 chitinase 3-like 3 3.67 8.38 26.19
Gsdmc gasdermin C 5.18 9.70 22.88
Ccl8 chemokine (C-C motif) ligand 8 6.09 10.59 22.68
S100a8 S100 calcium binding protein A8 (calgranulin A) 6.60 11.03 21.60
Cxcl5 chemokine (C-X-C motif) ligand 5 6.93 11.10 17.96
Igj immunoglobulin joining chain 5.48 9.64 17.95
Pip prolactin induced protein 4.55 8.69 17.72
Ear11 eosinophil-associated, ribonuclease A family, member 11 3.50 7.64 17.65
Sprr2a small proline-rich protein 2A 7.55 11.69 17.65
Srgn serglycin 7.01 11.15 17.63
Saa3 serum amyloid A 3 5.00 9.04 16.45
Ms4a6d membrane-spanning 4-domains, subfamily A, member 6D 3.92 7.81 14.76
Clca1 chloride channel calcium activated 1 3.84 7.61 13.71
Chi3l4 chitinase 3-like 4 7.05 10.80 13.50
Mrc1 mannose receptor, C type 1 5.27 9.00 13.25
Aqp4 aquaporin 4 3.99 7.70 13.03
Fcgr2b Fc receptor, IgG, low affinity IIb 4.66 8.29 12.43
Ccl24 chemokine (C-C motif) ligand 24 3.32 6.96 12.42
Serpina3g serine (or cysteine) peptidase inhibitor, clade A, member 3G 4.63 8.21 11.96
Nlrp10 NLR family, pyrin domain containing 10 4.43 7.98 11.74
Igl-V1 immunoglobulin lambda chain, variable 1 3.32 6.80 11.15
S100a9 S100 calcium binding protein A9 (calgranulin B) 7.47 10.92 10.97
Ccr1 chemokine (C-C motif) receptor 1 3.96 7.41 10.92
Chi3l1 chitinase 3-like 1 7.83 11.27 10.91
Csf3r colony stimulating factor 3 receptor (granulocyte) 4.01 7.43 10.71
Il1b interleukin 1 beta 5.71 9.11 10.56
Clec4d C-type lectin domain family 4, member d 3.84 7.23 10.51
Mfap4 microfibrillar-associated protein 4 3.94 7.30 10.33
C1qa complement component 1, q subcomponent, alpha polypeptide 6.22 9.58 10.25
Mmp3 matrix metallopeptidase 3 8.19 11.50 9.89
H2-Ab1 histocompatibility 2, class II antigen A, beta 1 5.92 9.20 9.72
Igh-6 immunoglobulin heavy chain 6 (heavy chain of IgM) 5.26 8.51 9.49
Clec7a C-type lectin domain family 7, member a 5.31 8.54 9.39
Tyrobp TYRO protein tyrosine kinase binding protein 5.16 8.37 9.25
Lcn2 lipocalin 2 8.71 11.92 9.24
Cxcl13 chemokine (C-X-C motif) ligand 13 3.85 7.04 9.12
Mmp13 matrix metallopeptidase 13 4.73 7.92 9.09
Cytip cytohesin 1 interacting protein 5.98 9.16 9.06
Nrsn1 neurensin 1 3.77 6.93 8.96
Gatm glycine amidinotransferase (L-arginine:glycine amidinotransferase) 4.46 7.62 8.95
S1pr3 sphingosine-1-phosphate receptor 3 4.00 7.15 8.91
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Table 5. Cont.
Gene symbol Description
Mean log intensity
in WT
Mean log intensity
in Klf5CN Fold Difference
Mcpt2 mast cell protease 2 3.40 6.53 8.77
Ccl9 chemokine (C-C motif) ligand 9 5.93 9.06 8.74
Genes whose expression is also increased in the PN11 Klf5CN corneas are shown in bold.
doi:10.1371/journal.pone.0044771.t005
Table 6. Top 50 genes whose expression is most increased during post-eyelid opening WT corneal maturation between PN11 and
PN56.
Gene symbol Description
Mean log intensity
in PN11
Mean log intensity
in PN56
Fold
Difference
Dsp desmoplakin 3.56 10.89 160.99
Lce3a late cornified envelope 3A 3.32 10.19 116.53
Scd2 stearoyl-Coenzyme A desaturase 2 4.05 10.28 75.18
Psca prostate stem cell antigen 6.24 11.98 53.45
Clca4 chloride channel calcium activated 4 3.44 8.65 37.16
Dsc3 desmocollin 3 4.79 9.89 34.31
Il1f9 interleukin 1 family, member 9 4.88 9.96 33.83
Lce3c late cornified envelope 3C 3.32 8.12 27.78
Oasl1 oligoadenylate synthetase-like 1 5.47 10.26 27.52
Vps35 vacuolar protein sorting 35 3.95 8.67 26.32
Piga phosphatidylinositol glycan anchor biosynthesis, class A 4.69 9.41 26.29
Prkci protein kinase C, iota 4.15 8.79 25.04
Expi extracellular proteinase inhibitor 6.16 10.76 24.20
Ggta1 glycoprotein galactosyltransferase alpha 1, 3 3.32 7.91 24.00
Il1f6 interleukin 1 family, member 6 3.91 8.45 23.34
Hif1a hypoxia inducible factor 1, alpha subunit 3.80 8.24 21.65
Met met proto-oncogene 3.75 8.15 21.23
Mobkl1b MOB1, Mps One Binder kinase activator-like 1B (yeast) 4.60 9.00 21.15
Sema4d sema domain, immunoglobulin domain (Ig), transmembrane domain
(TM) and short cytoplasmic domain, (semaphorin) 4D
3.32 7.70 20.75
Pdcd6ip programmed cell death 6 interacting protein 4.61 8.97 20.44
Mxd1 MAX dimerization protein 1 4.03 8.38 20.43
Pdlim5 PDZ and LIM domain 5 4.51 8.80 19.54
Sprr2a small proline-rich protein 2A 3.32 7.55 18.73
Lin7c lin-7 homolog C (C. elegans) 4.44 8.58 17.56
Sftpd surfactant associated protein D 4.11 8.24 17.49
Adam10 a disintegrin and metallopeptidase domain 10 3.58 7.70 17.47
Vcl Vinculin 3.32 7.44 17.42
Trp63 transformation related protein 63 3.71 7.82 17.28
Tgfbr1 transforming growth factor, beta receptor I 3.32 7.38 16.67
Slc1a1 solute carrier family 1 (neuronal/epithelial high affinity glutamate
transporter, system Xag), member 1
4.61 8.54 15.26
Spink5 serine peptidase inhibitor, Kazal type 5 5.38 9.30 15.21
Sdcbp2 syndecan binding protein (syntenin) 2 4.54 8.46 15.07
Gja1 gap junction protein, alpha 1 6.03 9.91 14.68
Obfc2a oligonucleotide/oligosaccharide-binding fold containing 2A 4.96 8.82 14.50
Cxadr coxsackie virus and adenovirus receptor 3.75 7.61 14.50
Mff mitochondrial fission factor 7.34 11.19 14.37
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Table 6. Cont.
Gene symbol Description
Mean log intensity
in PN11
Mean log intensity
in PN56
Fold
Difference
Sprr1a small proline-rich protein 1A 5.86 9.69 14.26
Clic5 chloride intracellular channel 5 4.48 8.26 13.78
Nr1d2 nuclear receptor subfamily 1, group D, member 2 3.32 7.10 13.74
Pax6 paired box gene 6 4.54 8.30 13.60
Gch1 GTP cyclohydrolase 1 4.66 8.43 13.56
Il1a interleukin 1 alpha 4.09 7.84 13.45
Dnm1l dynamin 1-like 3.32 7.07 13.39
Ide insulin degrading enzyme 4.54 8.28 13.39
Slc5a1 solute carrier family 5 (sodium/glucose cotransporter), member 1 7.41 11.14 13.28
Dock1 dedicator of cytokinesis 1 3.39 7.10 13.10
Sgpl1 sphingosine phosphate lyase 1 3.32 7.03 13.06
Malat1 metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) 7.96 11.66 13.05
Slc19a2 solute carrier family 19 (thiamine transporter), member 2 4.74 8.44 13.00
Atrx alpha thalassemia/mental retardation syndrome X-linked homolog (human) 3.32 7.00 12.79
Genes encoding cell junctional complex components or markers of epithelial stratification are shown in bold.
doi:10.1371/journal.pone.0044771.t006
Table 7. Top 50 genes whose expression is most decreased during post-eyelid opening WT corneal maturation between PN11 and
PN56.
Gene symbol Description
Mean log intensity
in PN11
Mean log intensity
in PN56
Fold
Difference
Mfap4 microfibrillar-associated protein 4 11.77 3.94 0.00
Cpz carboxypeptidase Z 10.50 3.59 0.01
Col11a1 collagen, type XI, alpha 1 10.77 4.05 0.01
Col9a1 collagen, type IX, alpha 1 11.51 4.81 0.01
Col5a2 collagen, type V, alpha 2 12.06 5.95 0.01
Meg3 maternally expressed 3 11.22 5.14 0.02
Col5a1 collagen, type V, alpha 1 10.43 4.50 0.02
Dlk1 delta-like 1 homolog (Drosophila) 10.15 4.23 0.02
Agtr2 angiotensin II receptor, type 2 10.19 4.28 0.02
Fmod fibromodulin 11.95 6.08 0.02
Rian RNA imprinted and accumulated in nucleus 9.47 3.61 0.02
H19 H19 fetal liver mRNA 11.32 5.48 0.02
Adamts2 a disintegrin-like and metallopeptidase (reprolysin type) with
thrombospondin type 1 motif, 2
9.48 3.68 0.02
Matn4 matrilin 4 11.63 5.95 0.02
Col3a1 collagen, type III, alpha 1 11.26 5.81 0.02
Pik3cd phosphatidylinositol 3-kinase catalytic delta polypeptide 12.06 6.73 0.03
Thbs2 thrombospondin 2 11.78 6.49 0.03
Twist2 twist homolog 2 (Drosophila) 9.03 3.82 0.03
Clec3b C-type lectin domain family 3, member b 8.77 3.57 0.03
Aplnr apelin receptor 9.21 4.04 0.03
Cryga crystallin, gamma A 9.02 3.89 0.03
Mfap2 microfibrillar-associated protein 2 11.15 6.07 0.03
Fbn2 fibrillin 2 9.06 4.00 0.03
Ctsk cathepsin K 11.39 6.39 0.03
Dpep1 dipeptidase 1 (renal) 10.50 5.53 0.03
Col6a2 collagen, type VI, alpha 2 12.35 7.49 0.03
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expression increased in PN56 Klf4CN and both PN11 and PN56
Klf5CN corneas (Atf3, Litaf, Runx1, Nfkbie and Fhl2; Table 12) are
known to be upregulated during inflammation [54–57], raising a
possibility that their increased expression reflects pro-inflammato-
ry conditions in these corneas and may not be due to direct de-
repression in the absence of Klf4 or Klf5.
In order to identify if a regulatory relationship exists between
different Klfs, we examined the effect of disruption of Klf5 on
expression of other Klfs in the cornea. While transcripts for Klfs 1,
14 and 15 were essentially absent in the cornea, those for Klfs 2, 4,
6, 7, 10, 11, 12, 16 and 17 were present in all samples but showed
no robust changes. During WT corneal maturation, the expression
of Klfs 3, 5 and 6 was increased, while that of Klfs 2, 12 and 13 was
decreased in PN56 compared with the PN11 corneas. Klf4 and
Klf5 remained unaffected in Klf5CN and Klf4CN corneas,
respectively, suggesting a lack of regulatory relationship between
these two Klfs highly expressed in the cornea. The closely related
Klf9 and Klf13 [27] were both increased in both Klf4CN and
Klf5CN corneas, suggesting that Klf9 and Klf13 show similar
compensatory changes whether Klf5 or Klf4 is ablated. Whether
this represents a true regulatory relationship among Klfs 4, 5, 9
and 13 in the mouse cornea remains to be established.
Discussion
Previously, we demonstrated that disruption of Klf5 resulted in
defective maturation of the mouse cornea in post-eyelid opening
stages [31]. Here, we have employed microarray analysis to obtain
a comprehensive view of the changes in corneal gene expression
upon deletion of Klf5 in immature corneas around eyelid opening
(PN11) and in adult (PN56) corneas. Our findings reveal the
molecular basis of the wide ranging influence of Klf5 on corneal
homeostasis and identify candidate target genes of Klf5 in the
mouse cornea. In addition, the design of our study allowed us to
identify the changes in gene expression between PN11 and PN56
WT corneas.
Earlier reports of Klf5-target gene profiling used chromatin
immunoprecipitation followed by microarray (ChIP-Array) in
embryonic stem cells [58], or microarray analysis following
selective disruption of Klf5 in the mouse lung [59] or bladder
urothelium [60]. Our results are largely consistent with those
findings and identify additional Klf5-target genes such as Pax6 and
Dsg1a, which play critical roles in the cornea. Differences in Klf5-
target genes in the cornea (this study), ESCs [58], lung [59] and
bladder urothelium [60] provide evidence for tissue-dependent
Table 7. Cont.
Gene symbol Description
Mean log intensity
in PN11
Mean log intensity
in PN56
Fold
Difference
Kazald1 Kazal-type serine peptidase inhibitor domain 1 9.89 5.05 0.04
Aspn Aspirin 9.25 4.41 0.04
Mmp23 matrix metallopeptidase 23 8.04 3.32 0.04
Thbs4 thrombospondin 4 11.04 6.35 0.04
Camk4 calcium/calmodulin-dependent protein kinase IV 8.28 3.60 0.04
C1qtnf2 C1q and tumor necrosis factor related protein 2 9.40 4.80 0.04
Mcpt4 mast cell protease 4 8.04 3.44 0.04
Itih5 inter-alpha (globulin) inhibitor H5 8.06 3.47 0.04
Pi16 peptidase inhibitor 16 8.09 3.51 0.04
Lox lysyl oxidase 11.18 6.60 0.04
Mfap5 microfibrillar associated protein 5 8.13 3.60 0.04
Col6a1 collagen, type VI, alpha 1 12.49 7.97 0.04
Col24a1 collagen, type XXIV, alpha 1 7.84 3.32 0.04
Aebp1 AE binding protein 1 9.73 5.22 0.04
Pycr1 pyrroline-5-carboxylate reductase 1 8.34 3.84 0.04
Mmp2 matrix metallopeptidase 2 11.37 6.87 0.04
Pdgfrl platelet-derived growth factor receptor-like 11.01 6.54 0.05
B3gnt9 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminy
ltransferase 9
8.44 3.98 0.05
Tac1 tachykinin 1 8.86 4.41 0.05
Angptl7 angiopoietin-like 7 11.61 7.17 0.05
Creb3l1 cAMP responsive element binding protein 3-like 1 8.40 3.96 0.05
Cgref1 cell growth regulator with EF hand domain 1 7.74 3.32 0.05
Gpx7 glutathione peroxidase 7 9.69 5.27 0.05
Gpr124 G protein-coupled receptor 124 8.53 4.13 0.05
Igfbp4 insulin-like growth factor binding protein 4 11.62 7.24 0.05
ECM-associated genes are shown in bold.
doi:10.1371/journal.pone.0044771.t007
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functions of Klf5. For example, disruption of Klf5 resulted in
increased expression of surfactant protein-D (Sftpd) in corneas
(Table 2), in contrast to decreased expression in the lung [59],
highlighting tissue-dependent functions of Klf5.
A striking feature of our results is the large number of genes
whose expression is influenced by the absence of Klf5 in the mouse
cornea. By comparison with similar studies of transcription factors
such as FoxP2 [61], Sox2 [62], Myb [63] and Bcl11b [64], we
predict that Klf5 is likely to directly regulate only a fraction of
those genes whose expression is modulated in the Klf5CN corneas.
The remaining genes are expected to be indirect targets of Klf5,
through other transcription factors such as Pax6 [48–50,65],
whose expression is reduced in Klf5CN corneas (Table 12).
Alternatively, they may represent physiological responses to the
phenotype brought about by disruption of Klf5. For example, a
large number of genes upregulated in Klf5CN corneas are immune
response related, consistent with the massive infiltration of CD45+
cells (Fig. 3), and may not be directly regulated by Klf5. Though it
is likely that the Klf5CN corneal neovascularization and influx of
CD45+ cells indirectly contributed to increased expression of
many of the immune response related genes, a similar effect may
not be extended to a majority of the negatively regulated genes,
which are more likely to represent true targets for Klf5.
Table 8. Expression of ECM-related genes between PN11 and
PN56.
Gene
symbol Description
Mean log
intensity
for PN11
Mean log
intensity
for PN56
Fold
Diffe-
rence
A. Collagens
Col11a1 collagen, type XI, alpha 1 10.77 4.05 0.01
Col9a1 collagen, type IX, alpha 1 11.51 4.81 0.01
Col5a2 collagen, type V, alpha 2 12.06 5.95 0.01
Col5a1 collagen, type V, alpha 1 10.43 4.50 0.02
Col3a1 collagen, type III, alpha 1 11.26 5.81 0.02
Col6a2 collagen, type VI, alpha 2 12.35 7.49 0.03
Col6a1 collagen, type VI, alpha 1 12.49 7.97 0.04
Col24a1 collagen, type XXIV, alpha 1 7.84 3.32 0.04
Col1a2 collagen, type I, alpha 2 13.04 8.71 0.05
Col14a1 collagen, type XIV, alpha 1 9.76 5.75 0.06
Col27a1 collagen, type XXVII, alpha 1 8.78 5.03 0.07
Col1a1 collagen, type I, alpha 1 12.83 9.08 0.08
Col2a1 collagen, type II, alpha 1 7.02 3.32 0.08
Col16a1 collagen, type XVI, alpha 1 10.92 7.52 0.10
Col11a2 collagen, type XI, alpha 2 7.33 4.04 0.10
Col6a3 collagen, type VI, alpha 3 12.48 9.36 0.12
Col5a3 collagen, type V, alpha 3 7.56 4.47 0.12
Col13a1 collagen, type XIII, alpha 1 7.10 4.11 0.13
Col15a1 collagen, type XV, alpha 1 6.78 3.85 0.13
Col20a1 collagen, type XX, alpha 1 6.01 3.32 0.16
Col4a2 collagen, type IV, alpha 2 10.76 8.37 0.19
Col8a1 collagen, type VIII, alpha 1 10.90 8.51 0.19
Col4a1 collagen, type IV, alpha 1 11.14 8.99 0.23
Col12a1 collagen, type XII, alpha 1 12.32 10.45 0.28
Col18a1 collagen, type XVIII, alpha 1 7.48 5.64 0.28
Col4a5 collagen, type IV, alpha 5 11.08 9.81 0.42
Col23a1 collagen, type XXIII, alpha 1 6.44 5.22 0.43
Col7a1 collagen, type VII, alpha 1 9.90 8.74 0.45
B. Other ECM-related proteins
Lamb1-1 laminin B1 subunit 1 8.68 7.56 0.46
Lama1 laminin, alpha 1 5.30 3.32 0.25
Lama2 laminin, alpha 2 8.86 5.40 0.09
Lama4 laminin, alpha 4 7.65 3.41 0.05
Lamb2 laminin, beta 2 8.33 6.32 0.25
Lamc1 laminin, gamma 1 9.09 7.01 0.24
Lgals1 lectin, galactose binding,
soluble 1
11.61 8.00 0.08
Lgals7 lectin, galactose binding,
soluble 7
8.13 6.13 0.25
Lman1 lectin, mannose-binding, 1 9.95 8.89 0.48
Lum Lumican 12.81 10.12 0.16
Sdc2 syndecan 2 7.75 6.68 0.48
Sdc3 syndecan 3 8.86 6.07 0.15
Sdc4 syndecan 4 10.70 8.21 0.18
Kera keratocan 12.81 9.27 0.09
Vim vimentin 11.64 8.46 0.11
Fndc1 fibronectin type III domain
containing 1
9.31 6.74 0.17
Table 8. Cont.
Gene
symbol Description
Mean log
intensity
for PN11
Mean log
intensity
for PN56
Fold
Diffe-
rence
Fndc3b fibronectin type III domain
containing 3B
9.45 8.13 0.40
Fndc4 fibronectin type III domain
containing 4
6.29 4.22 0.24
Fndc5 fibronectin type III domain
containing 5
6.34 3.69 0.16
Chad chondroadherin 7.63 4.18 0.09
Chpf chondroitin polymerizing
factor
8.01 5.53 0.18
Chpf2 chondroitin polymerizing
factor 2
8.41 6.42 0.25
Chsy3 chondroitin sulfate
synthase 3
8.48 5.71 0.15
Chst1 carbohydrate (keratan
sulfate Gal-6)
sulfotransferase 1
5.81 4.76 0.48
Chst14 carbohydrate (N-
acetylgalactosamine 4-0)
sulfotransferase 14
7.87 6.29 0.33
Chst5 carbohydrate (N-
acetylglucosamine 6-O)
sulfotransferase 5
10.46 9.15 0.40
Chst7 carbohydrate (N-
acetylglucosamino)
sulfotransferase 7
6.16 3.62 0.17
Chst11 carbohydrate
sulfotransferase 11
7.89 5.63 0.21
Chst12 carbohydrate
sulfotransferase 12
7.30 6.03 0.41
Chst2 carbohydrate
sulfotransferase 2
5.93 3.71 0.22
Has2 hyaluronan synthase 2 7.34 5.83 0.35
doi:10.1371/journal.pone.0044771.t008
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Klf4 and Klf5 are both abundantly expressed in the mouse
cornea [29], where they play critical, non-redundant roles [22,31].
In order to understand the molecular basis for their corneal
functions, it is necessary to identify and distinguish their target
genes. Comparison of the Klf5CN corneal gene expression profile
(this study) with that of Klf4CN corneas [21] revealed that roughly
2/3 of the corneal Klf4- and Klf5-target genes are Klf4- or Klf5-
specific, with the rest being common targets. Canonical pathway
analysis of genes exclusively modulated by Klf4 yielded ‘‘human
embryonic stem cell pluripotency’’ as the most significantly
enriched (p,1025) pathway, in agreement with the importance
of KLF4 in inducing pluripotency [66]. In contrast, ‘‘hepatic
fibrosis/hepatic stellate cell activation’’ was the most significantly
enriched (p,10212) pathway among the genes exclusively
modulated by Klf5 (Table S10), indicative of a general fibrotic
response such as that observed in cultured human keratocytes
exposed to TGF-b [67]. Molecular basis for the ability of Klf4 and
Klf5 to regulate distinct sets of target genes in spite of possessing
identical DNA-binding domain remains to be understood.
Genome-wide identification of the nucleotide sequence of Klf4-
and Klf5-bound cis-elements by chromatin immunoprecipitation
followed by large scale sequencing (ChIP-Seq) is necessary to
better understand target site selection by Klf4 and Klf5.
Being environmentally exposed, the cornea is frequently
exposed to xenobiotic stress. Also, when the eyelids are closed
during sleep, the avascular cornea is subjected to almost 75% drop
in oxygen partial pressure [68,69]. Thus, hypoxic and xenobiotic
response pathways are expected to play an active role in corneal
homeostasis. The important role of inhibitory PAS domain protein
(IPAS) - a hypoxia repressor protein- in maintaining corneal
avascularity [70,71] further supports this contention. Moreover,
corneal crystallin genes are induced by hypoxia or xenobiotics,
further implicating hypoxic and xenobiotic stress in corneal gene
expression [16,72,73]. Our data demonstrated significant enrich-
ment of xenobiotic metabolism-related pathways among genes
whose expression is decreased in Klf5CN corneas (Table 11). Thus,
we suggest that Klf5 serves an important role in detoxification of
the environmentally exposed avascular cornea, by supporting the
expression of xenobiotic metabolism related genes.
Important changes take place in the mouse cornea as it matures
following eyelid opening around PN12 [8,74]. This study
identified the changes in corneal gene expression between PN11
and PN56, revealing the molecular events underlying post-eyelid
opening corneal maturation. Specifically, we demonstrate that
during WT corneal maturation between PN11 and PN56,
transcripts encoding (i) ECM components are sharply decreased,
(ii) epithelial barrier-related proteins are sharply increased, and
(iii) members of the solute carrier family proteins are elevated,
consistent with (a) the active formation of stromal ECM around
eyelid opening, with little remodeling taking place in adult corneal
stroma, (b) rapid stratification of squamous epithelium in post-
eyelid opening stages and (c) elevated demand for solute transport
in the metabolically active adult cornea, respectively.
We compared the present data with a previous analysis of
changes in corneal gene expression associated with post-eyelid
opening maturation [75], which used Affymetrix MG74Av2 chips
targeting a subset (8,666) of the 21,815 unique characterized genes
examined here. Applying the present selection rules to their data
[75] yielded 442 genes differentially expressed between their
immature (PN10) and adult (PN49 to PN56) groups. Though there
were differences between the two datasets (which could be
attributed to several factors including differences in the mouse
Table 9. Expression of metalloproteinases and other genes associated with matrix remodeling between PN11 and PN56.
Gene symbol Description
Mean log
intensity
for PN11
Mean log
intensity
for PN56
Fold
Difference
A. Decreased Expression
Adamts2 a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 2 9.48 3.68 0.02
Adam33 a disintegrin and metallopeptidase domain 33 7.08 3.96 0.12
Adamts12 a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 12 6.55 3.52 0.12
Adam22 a disintegrin and metallopeptidase domain 22 6.96 4.46 0.18
Adamts10 a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 10 8.05 5.83 0.22
Adamts9 a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9 6.34 4.76 0.33
Adamts3 a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 6.68 5.61 0.48
Mmp23 matrix metallopeptidase 23 8.04 3.32 0.04
Mmp2 matrix metallopeptidase 2 11.37 6.87 0.04
Mmp14 matrix metallopeptidase 14 (membrane-inserted) 9.59 5.52 0.06
Mmp16 matrix metallopeptidase 16 5.85 3.40 0.18
Mmp15 matrix metallopeptidase 15 7.38 5.83 0.34
Mxra8 matrix-remodeling associated 8 10.66 8.48 0.22
Mxra7 matrix-remodeling associated 7 7.65 6.15 0.35
B. Increased Expression
Adam10 a disintegrin and metallopeptidase domain 10 3.58 7.70 17.47
Adam17 a disintegrin and metallopeptidase domain 17 5.07 7.41 5.06
Adamts1 a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 6.69 8.25 2.96
doi:10.1371/journal.pone.0044771.t009
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strains used, the nature of microarray chips used, and the
parameters employed in filtering and analyzing the microarray
data), our study confirmed 202 (45.7%) of these genes as
differentially expressed between PN11 and PN56 corneas, with
36 concordant increases and 149 concordant decreases (7.0 and
5.1 times the number expected by contingency analysis, respec-
tively, with a x2 test yielding p= 6.86102161). Thus, the current
study confirmed and expanded our knowledge of the changes in
gene expression associated with post-eyelid opening corneal
maturation [29,75].
In summary, this report identifies dynamic changes in gene
expression accompanying post-eyelid opening corneal maturation,
and the role of Klf5 in this process. Our results show that Klf5
contributes to maturation and maintenance of cornea by
regulating the expression of subsets of genes involved in specific
functions such as cell-cell adhesion, epithelial barrier formation,
maintenance of proper level of hydration and xenobiotic
metabolism. The changes in Klf5CN corneal gene expression are
consistent with the elevated immune response and CNV. These
results also revealed significant differences between Klf4- and
Klf5-target genes, consistent with their non-redundant roles in the
mouse cornea. Taken together with our previous report [22], the
present studies establish Klf5 as another important node in the
Table 10. WT corneal expression of solute carrier family members increased between PN11 and PN56.
Gene symbol Description
Mean log
intensity
in PN11
Mean log
intensity
in PN56
Fold
Difference
Slc1a1 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 4.61 8.54 15.26
Slc5a1 solute carrier family 5 (sodium/glucose cotransporter), member 1 7.41 11.14 13.28
Slc19a2 solute carrier family 19 (thiamine transporter), member 2 4.74 8.44 13.00
Slc6a14 solute carrier family 6 (neurotransmitter transporter), member 14 7.93 11.48 11.70
Slc28a3 solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 5.34 8.72 10.40
Slc39a8 solute carrier family 39 (metal ion transporter), member 8 4.95 8.22 9.63
Slc4a11 solute carrier family 4, sodium bicarbonate transporter-like, member 11 6.43 9.40 7.84
Slc35a3 solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member 3 4.36 7.02 6.31
Slc22a4 solute carrier family 22 (organic cation transporter), member 4 3.65 6.08 5.41
Slc12a2 solute carrier family 12, member 2 7.94 10.26 4.99
Slc39a6 solute carrier family 39 (metal ion transporter), member 6 5.16 7.47 4.97
Slc25a15 solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15 3.62 5.76 4.42
Slc10a7 solute carrier family 10 (sodium/bile acid cotransporter family), member 7 3.48 5.60 4.35
Slc6a6 solute carrier family 6 (neurotransmitter transporter, taurine), member 6 3.32 5.35 4.09
Slc14a1 solute carrier family 14 (urea transporter), member 1 6.62 8.54 3.76
Slc25a24 solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24 6.85 8.68 3.55
Slc38a9 solute carrier family 38, member 9 4.24 5.96 3.29
Slc22a5 solute carrier family 22 (organic cation transporter), member 5 5.20 6.64 2.71
Slc25a30 solute carrier family 25, member 30 4.72 6.15 2.69
Slc11a2 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 6.50 7.92 2.68
Slc37a1 solute carrier family 37 (glycerol-3-phosphate transporter), member 1 6.91 8.32 2.66
Slco4a1 solute carrier organic anion transporter family, member 4a1 7.36 8.75 2.61
Slc4a7 solute carrier family 4, sodium bicarbonate cotransporter, member 7 4.65 5.99 2.54
Slc44a4 solute carrier family 44, member 4 7.12 8.44 2.50
Slc38a10 solute carrier family 38, member 10 5.19 6.44 2.38
Slc5a8 solute carrier family 5 (iodide transporter), member 8 8.21 9.45 2.36
Slc20a2 solute carrier family 20, member 2 6.11 7.35 2.36
Slc44a2 solute carrier family 44, member 2 6.08 7.31 2.34
Slc25a36 solute carrier family 25, member 36 6.30 7.51 2.32
Slc38a2 solute carrier family 38, member 2 8.38 9.57 2.27
Slc4a4 solute carrier family 4 (anion exchanger), member 4 6.91 8.09 2.27
Slc16a12 solute carrier family 16 (monocarboxylic acid transporters), member 12 8.60 9.76 2.24
Slc25a13 solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 7.49 8.62 2.20
Slc35b4 solute carrier family 35, member B4 5.66 6.79 2.19
Slc6a20a solute carrier family 6 (neurotransmitter transporter), member 20A 5.95 7.02 2.10
doi:10.1371/journal.pone.0044771.t010
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genetic network of transcription factors required for corneal
maturation and maintenance.
Materials and Methods
Ethics Statement
Mice used in these studies were maintained in accordance with
the guidelines set forth by the Institutional Animal Care and Use
Committee (IACUC) of the University of Pittsburgh, and the
ARVO statement on the use of animals in ophthalmic and vision
research. All procedures performed on mice reported in this study
were approved by the University of Pittsburgh IACUC.
Conditional disruption of Klf5
Klf5CN mice were generated on a mixed background by mating
Klf5loxP/loxP, Le-Cre/- mice with Klf5loxP/loxP mice as described before
[31]. This mating scheme generated equal numbers of Klf5loxP/loxP,
Le-Cre/- (Klf5CN) and Klf5loxP/loxP (control) offspring. Genomic
DNA isolated from tail clippings was assayed for the presence of
the Klf5-LoxP and Le-Cre transgenes by PCR using specific primers.
Isolation of total RNA, quality control, labeling and
microarray analysis
WT and Klf5CN littermates (4 each at PN56 and 3 each at
PN11) were used for comparison of corneal gene expression by
microarrays. All corneas used in these studies were microdissected
from freshly harvested eyeballs under a surgical microscope.
Corneas were dissected using a pair of fine scissors (RS-5611
Vannas Curved Spring Scissors; Roboz Surgical Company,
Germany) around the limbus, ensuring that they are free of
contamination from iris, ciliary body and/or trabecular mesh-
work. Two dissected corneas from each mouse were pooled for
isolation of total RNA using the RNeasy Mini kit (Qiagen,
Germantown, MD). The quality and integrity of the isolated total
RNA was confirmed using an Agilent Bioanalyzer (Figure S1);
1.0 mg sample RNAs were subsequently amplified and labeled
using a 39 IVT Express Kit (Affymetrix Inc., Santa Clara, CA) and
hybridized to Affymetrix MG 430 2 chips [33]. Utilization of the
same amount of total RNA (1.0 mg) from WT and Klf5CN corneas
for labeling and hybridization ensured that the smaller size of
Klf5CN corneas did not skew the microarray results.
The raw data obtained from microarray analysis were processed
using Affymetrix GeneChip Operating Software (GCOS v 1.4)
using software defaults, to assess the presence or absence of each
transcript target sequence, its expression level, and then to make
all relevant pair-wise statistical comparisons among samples.
Expression levels were scaled to a target value of 150 using the
software default (2% trimmed mean). Prior to scaling, mean
microarray expression levels were 449638 (mean 6 SD, n= 13
with one outlier of 255), and target sequences were detected (called
Present) for 57.8%62.5% (mean 6 SD, n= 14) of panels on the
chip. After scaling, three redundant panels for the housekeeping
gene GAPDH reported coefficients of variation of 12.3%, 10.9%
and 13.1% respectively (n = 13 for each panel since each had one
outlier value).
Processed data were sorted and inspected in an Excel
spreadsheet (Microsoft, Redmond, WA) with BRB-ArrayTools
(www.linus.nci.nih.gov/BRB-ArrayTools.html). Genes were con-
Table 11. Canonical pathways enriched among genes with reduced expression in Klf5CN corneas.
PN11 Klf5CN PN56 Klf5CN Aggregate
Canonical Pathway (Total number of genes in pathway) 2log(p)
Number of
genes 2log(p)
Number of
genes 2log(p)
Number of
genes
LPS/IL-1 Mediated Inhibition of RXR Function (223) 4.5 11 3.62 8 5.67 15
Metabolism of Xenobiotics by Cytochrome P450 (197) 4.82 8 2.16 4 5.38 10
Glutathione Metabolism (92) 4.29 6 2 4.35 7
Xenobiotic Metabolism Signaling (296) 2.33 9 4.2 10 3.68 14
Arachidonic Acid Metabolism (208) 4.02 8 2 2.97 8
Fatty Acid Metabolism (185) 3.31 7 3 3.75 9
Glycerolipid Metabolism (154) 2.21 5 3 3.58 8
Mechanisms of Viral Exit from Host Cells (45) 2.84 4 1 3.18 5
Butanoate Metabolism (129) 3 3 3.08 6
Eicosanoid Signaling (77) 3.05 5 1 2.36 5
Valine, Leucine and Isoleucine Degradation (108) 3 3 2.82 6
PXR/RXR Activation (89) 2 2.78 4 2.36 5
Cysteine Metabolism (90) 2.6 4 2 2.04 4
Retinol Metabolism (61) 1 2.56 3 2.56 4
Propanoate Metabolism (122) 2 3 2.36 5
NRF2-mediated Oxidative Stress Response (192) 6 5 2.27 9
Chondroitin Sulfate Biosynthesis (68) 3 2.19 3 2.08 4
Aryl Hydrocarbon Receptor Signaling (159) 4 2.18 5 7
Urea Cycle and Metabolism of Amino Groups (78) 2.14 3 3
b-alanine Metabolism (93) 1 2.11 3 4
Pathways were selected where at least one group was significantly enriched at p,0.01 (i.e., 2log(p).2). For clarity, 2log(p) cells are left blank if 2log(p),2.
doi:10.1371/journal.pone.0044771.t011
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sidered differentially expressed between any two groups if they
satisfied the following four criteria: (1) the average value for the
high-expression group was .2 fold greater than the average value
for the low expression group; (2) the high-expression group
contained at least 3 detectable transcripts (called Present); (3) the
differences between groups were significant at p#0.057 in a two-
tailed Mann-Whitney rank sum test. As this requirement could not
be met in the PN11 WT vs. PN11 Klf5CN comparison, we
required the minimum p value possible (0.1) instead; (4) for groups
of m and n members, where m$n, of the (m6n) pair-wise
comparisons made by the GCOS software, at least ((m - 1)6n)
show valid differences. We re-analyzed the previously published
Klf4CN [21] data using current filters to compare PN56 WT
corneas with Klf4CN corneas, at a cutoff of p= 0.063 in the Mann-
Whitney test. MIAME-compliant microarray data were submitted
to NCBI GEO (http://www.ncbi.nlm.nih.gov/geo/; Accession
Number GSE36229).
Validation of microarray results by real time QPCR
Applied Biosystems (ABI: Foster City, CA) was the source of the
reagents, equipment and software for quantitative real time RT-
PCR assays (QPCR). Total RNA isolated from pooled corneas of
10 WT or Klf5CN mice was quantified and the concentration
adjusted with RNase-free water to 100 ng/ml. cDNA was
generated using an ABI High Capacity cDNA Archive Kit and
real-time QPCR assays were performed in a ABI StepOnePlus
thermocycler using GAPDH as endogenous control for SYBR
green assays and Pcx (pyruvate carboxylase) as endogenous control
for FAM assays; the results were analyzed using ABI StepOnePlus
software. Nucleotide sequence of different primers used is given in
Table S1.
Immunofluorescent staining of corneal whole mounts
Corneas were dissected, flattened by three radial incisions,
washed 3 times for 15 minutes each in PBS with 4% FBS and
blocked in FC block (BD Pharmingen, San Jose, CA) for
20 minutes prior to incubation with FITC-conjugated anti-
CD45 antibody, or FITC-conjugated anti-Lyve1 antibody and
PE-conjugated anti-CD31 antibody (BD Pharmingen) overnight at
4uC. Corneas were then washed three times each for 30 minutes
in PBS/4% FBS, fixed in 1% Paraformaldehyde for 2 hours at
4uC, rinsed 3 times again for 30 minutes each in PBS/4% FBS
Figure 3. Enhanced influx of CD45+ cells into Klf5CN corneas. Flat mounts of PN56 WT (A) and Klf5CN (B) corneas were stained with FITC-
conjugated anti-CD45 antibody and examined by confocal microscopy. Representative stacked images of the central corneal stroma are shown at
606magnification (Panels C–H). Compared with the WT stroma, enhanced influx of clusters of CD45+ cells is observed throughout the depth of
Klf5CN stromas. Scale bars: 1 mm in Panels A and B; 40 mm in Panels C–H. Data are representative of 4 independent experiments. Klf5CN corneas are
smaller than the WT, consistent with their small eye size reported previously.
doi:10.1371/journal.pone.0044771.g003
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and mounted in Aqua Poly/Mount (Polysciences Inc, Warrington,
PA). Images were acquired on a Nikon Ti-E and/or Olympus
Fluoview 1000 confocal system with an Olympus IX81 micro-
scope. Stacks were imaged at 206 (Numerical Aperture 0.85) and
606 (Numerical Aperture 1.42) through the cornea. Individual
images were stitched together using Metamorph (Molecular
Devices, Sunnyvale, CA) and Photoshop (Adobe Systems Inc.,
San Jose, CA) programs.
Immunofluorescence
Paraformaldehyde fixed, paraffin-embedded sections were
deparaffinized with xylene, blocked with 10% goat serum in
PBS for 1 h at room temperature (RT) in a humidified chamber,
washed twice with PBS for 5 minutes each, incubated overnight
with a 1:50 dilution of anti-Dsg (recognizes both Dsg1a and
Dsg1b) or anti-Dsp primary antibody raised in rabbit (Santa Cruz
Biotechnology, Santa Cruz, CA) at 4uC, washed thrice with PBS
for 5 minutes each, incubated with secondary antibody (Alexa-
Fluor 546-coupled goat anti-rabbit IgG antibody; Molecular
Probes, Carlsbad, CA) at a 1:300 dilution for 1 h at RT, washed
twice with PBS for 5 minutes each, incubated with DAPI for
10 minutes, mounted with Aqua Polymount (Polysciences, Inc),
and observed with a fluorescence microscope. All images
presented within each composite figure were acquired under
identical settings and processed in a similar manner using Adobe
Photoshop and Illustrator (Adobe, Mountain View, CA).
Reporter Vectors, Cell Culture, and Transient Transfection
Assays
Different reporter vectors where approximately 2 kb Dsg1a,
Dsg1b and Dsp promoter fragments drive the expression of
luciferase reporter gene were described earlier [47]. Full-length
Klf4 in pCI-Klf4 and full length Klf5 in pCMV-Sport-Klf5 was
transiently expressed using the CMV promoter. Human skin
Figure 4. Neovascularization in Klf5CN corneas. Flat mounts of PN21 and PN56 WT and Klf5CN corneas were subjected to immunofluorescent
staining with anti-CD31 (red) and anti-Lyve1 (green) antibody to detect blood vessels and lymph vessels, respectively. A–D, images of whole corneas
generated by stitching together individual images from adjacent areas (Panels A–D; Scale bars = 1 mm). Vessels were blocked from entering the
corneas at the limbus in WT but not Klf5CN corneas. Z-stack and XY-stacks of confocal images collected at 206 (panels E, G, I, K, M, O, Q and S; Scale
bars = 100 mm) and 606magnification (panels F, H, J, L, N, P, R and T; Scale bars = 50 mm) are shown. Data are representative of 4 independent
experiments. Klf5CN corneas are smaller than the WT, consistent with their small eye size reported previously.
doi:10.1371/journal.pone.0044771.g004
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keratinocyte NCTC cells were grown in Dulbecco’s modified
Eagle’s medium(DMEM) supplemented with 10% fetal bovine
serum, penicillin, and streptomycin at 37uC in a humidified
chamber containing 5% CO2 in air. NCTC cells in 12-well plates
were co-transfected with 0.5 mg pDsg1a-Luc, pDsg1b-Luc or pDsp-
Luc, along with 20 ng pRL-SV40 (for normalization of transfection
efficiency) and 0.5 mg pCI (control), or 0.25 mg each of pCI and
pCI-Klf4, or pCI and pCMV-Sport6-Klf5, or pCI-Klf4 and pCMV-
Sport6-Klf5 using 2.5 mL transfection reagent (Expressfect; Denville
Scientific). After 2 days, cells were washed with PBS and lysed with
200 mL passive lysis buffer (Promega). 50 mL of lysate was
analyzed using a dual-luciferase assay kit (Promega) and a
microplate luminometer (Synergy-II; Biotek Instruments, Wi-
nooski, VT). The measurement was integrated over 10 seconds,
with a delay of 2 seconds. Firefly luciferase activity normalized for
transfection efficiency using the SV40 promoter-driven Renilla
luciferase activity, were used to obtain mean promoter activities.
Fold-activation was determined by dividing mean promoter
activity by the promoter activity with only pCI. Error bars
indicate Standard Error of Mean (SEM). Results presented are
representative of three independent experiments.
Figure 5. Klf5 contributes to corneal epithelial homeostasis by regulating the expression of desmogleins and desmoplakin. (A)
Immunofluorescence shows abundant expression of desmogleins (red, panel ii) and desmoplakin (red, panel v) in the WT but not in the Klf5CN
corneal epithelium (panels iii and vi, respectively). Sections processed in a similar manner but without the primary antibody served as negative
controls (panels i and iv). Scale bars = 25 mm. (B) Relative activities of 2 kb Dsg1a, Dsg1b and Dsp promoter fragments measured by transient co-
transfection assays with or without Klf4, Klf5, or both in NCTC cells. Error bars indicate Standard Error of Mean (SEM). Data are representative of three
independent experiments.
doi:10.1371/journal.pone.0044771.g005
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Supporting Information
Figure S1 Quality of RNA used for microarray analysis.
Total RNA isolated from PN11 and PN56 WT or Klf5CN corneas
was subjected to Agilent Bioanalyzer analysis using nanoRNA
chips. Resultant gel image confirming the RNA integrity is shown.
Corresponding RNA Integrity Value (RIN) numbers are provided
at the top of each lane.
(TIF)
Figure S2 Comparative analysis of the network of target
genes influenced by transcription factors that are
affected in Klf4CN corneas. Lists of transcription factors
downregulated by 1.5-fold in Klf4CN corneas (shaded yellow) were
submitted to Ingenuity Pathway Analysis (IPA), where gene
identifiers were mapped to their corresponding gene objects and
overlaid onto a global molecular network in the Ingenuity
Pathways Knowledge Base to generate the associated networks.
Direct relationships are shown with solid arrows and indirect
relationships with dashed arrows. Legends for different shapes
used are shown.
(TIF)
Figure S3 Comparative analysis of the network of target
genes influenced by transcription factors that are
affected in Klf5CN corneas. Lists of transcription factors
downregulated by 1.5-fold in Klf5CN corneas (shaded yellow) were
submitted to Ingenuity Pathway Analysis (IPA), where gene
identifiers were mapped to their corresponding gene objects and
overlaid onto a global molecular network in the Ingenuity
Pathways Knowledge Base to generate the associated networks.
Direct relationships are shown with solid arrows and indirect
relationships with dashed arrows. Legends for different shapes
used are shown.
(TIF)
Table S1 Sequence of nucleotide primers used for
QPCR.
(XLSX)
Table S2 Most downregulated genes in PN11 Klf5CN
corneas.
(XLS)
Table S3 Most upregulated genes in PN11 Klf5CN
corneas.
(XLS)
Table S4 Most downregulated genes in PN56 Klf5CN
corneas.
(XLS)
Table S5 Most upregulated genes in PN56 Klf5CN
corneas.
(XLS)
Table S6 Most upregulated genes in PN56 WT com-
pared with PN11 WT corneas.
(XLS)
Table S7 Most downregulated genes in PN56 compared
with PN11 WT corneas.
(XLS)
Table S8 Genes whose expression is decreased at PN56
in both Klf4CN and Klf5CN corneas. Transcription factors
are in bold. Genes are annotated by other effects as follows:
(*) = developmental effect, (**) = PN11 Klf5CN effect, (***) = both.
All 43 developmental effects are increases except Agpat3, Lamb1-
1, Ntn1, Satb1 and Tox. All 48 PN56 Klf5CN effects are decreases
except Vgll3.
(XLSX)
Table S9 Genes whose expression is increased in both
Klf4CN and Klf5CN corneas at PN56. Transcription factors
are highlighted in bold. Genes are annotated by the other effects.
Table 12. Transcription factors (TFs) differentially expressed in more than one comparison.
Transcription factor Klf4CN vs. WT (PN56) Klf5CN vs. WT (PN56) Klf5CN vs. WT (PN11) PN56 WT vs. PN11 WT
Klf5 1.14 0.028 0.027 2.20
Bnc1 0.36 0.45 0.27 (1.58)
Pax6 0.38 (0.64) 0.16 12.95
Cux1 0.37 (0.60) 0.47 3.56
Satb1 0.24 0.43 (0.56) 0.46
Tox 0.23 0.29 0.45 0.47
Sox4 8.19 4.16 2.10 0.32
Irf8 2.38 4.68 2.47 0.46
Mecom 1.8 2.30 (1.41) 0.33
Ar 1.24 2.85 (1.65) 0.38
Atf3 3.77 2.28 3.41 (1.55)
Fhl2 2.80 2.98 3.47 (0.77)
Litaf 2.04 2.52 2.78 (1.05)
Nfkbie 2.22 3.92 3.59 0.41
Runx1 2.70 2.05 2.60 2.49
In the first group, Bnc1, Pax6 and Cux1 have expression profiles most similar to Klf5, and therefore are strong candidates for direct control by Klf5 or for co-modulation
with Klf5 by an upstream modulator. Members of the second group (Sox4, Irf8, Mecom and Ar) have expression profiles which are the inverse of Klf5. The third group
shows increased expression in PN11 and PN56 Klf5CN, and PN56 Klf4CN corneas without a convincing change during WT corneal maturation. When the differences were
less than 2-fold, those values are shown in parenthesis.
doi:10.1371/journal.pone.0044771.t012
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(*) = developmental effect, (**) =Klf5CN effect in PN11 cornea
also, (***) = both. All changes in the PN11 Klf5CN are increases
and all developmental changes are decreases, except those shaded
grey.
(XLSX)
Table S10 Canonical pathways enriched in PN11 and
PN56 corneal Klf5-target genes or in developmentally-
modulated genes. Aggregates of differentially expressed genes
in PN11or PN56 Klf5CN corneas, and during WT corneal
maturation were subjected to canonical pathway analysis.
Pathways for which at least one group showed significant (2log(p)
.5) enrichment were selected. Where upregulated genes exceed
downregulated genes by .2-fold, cells are colored red; where
downregulated genes exceed upregulated genes by .2-fold, cells
are colored green. Otherwise cells are colored yellow. For Klf5CN
groups, significantly enriched pathways are dominated by
upregulated genes. Developmentally modulated pathways contain
a fair balance of up- and down-regulated genes.
(XLSX)
Table S11 Immune-related genes whose expression
changes in Klf5CN corneas. 107 of 368 immun/inflam genes
were upregulated in PN56 and/or PN11 Klf5CN corneas, with
only 7 genes downregulated. Entries in bold show the smaller
number of genes affected in PN56 Klf4CN corneas.
(XLSX)
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